Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and B...

por Jia, Qingmei, Masleša-Galić, Saša, Nava, Susana, Horwitz, Marcus A.
Publicado 2022

Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge

por Jia, Qingmei, Masleša-Galić, Saša, Nava, Susana, Horwitz, Marcus A.
Publicado 2022

Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia

por Jia, Qingmei, Bowen, Richard, Dillon, Barbara Jane, Masleša-Galić, Saša, Chang, Brennan T., Kaidi, Austin C., Horwitz, Marcus A.
Publicado 2018

Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters

por Jia, Qingmei, Bielefeldt-Ohmann, Helle, Maison, Rachel M., Hartwig, Airn, Masleša-Galić, Saša, Bowen, Richard A., Horwitz, Marcus A.
Publicado 2023

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

por Jia, Qingmei, Bielefeldt-Ohmann, Helle, Maison, Rachel M., Masleša-Galić, Saša, Cooper, Sarah K., Bowen, Richard A., Horwitz, Marcus A.
Publicado 2021

Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility

por Lee, Bai-Yu, Clemens, Daniel L., Silva, Aleidy, Dillon, Barbara Jane, Masleša-Galić, Saša, Nava, Susana, Ho, Chih-Ming, Horwitz, Marcus A.
Publicado 2018

Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time

por Lee, Bai-Yu, Clemens, Daniel L., Silva, Aleidy, Dillon, Barbara Jane, Masleša-Galić, Saša, Nava, Susana, Ding, Xianting, Ho, Chih-Ming, Horwitz, Marcus A.
Publicado 2017

Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs

por Clemens, Daniel L., Lee, Bai-Yu, Silva, Aleidy, Dillon, Barbara Jane, Masleša-Galić, Saša, Nava, Susana, Ding, Xianting, Ho, Chih-Ming, Horwitz, Marcus A.
Publicado 2019